Chemokines in cancer

Cytokine and Growth Factor Reviews

Volumn 13, Issue 2, 2002, Pages 143-154

  Vicari, Alain P ^a   Caux, Christophe ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Angiogenesis; Cancer; Chemokine; Dendritic cell; Macrophage; Metastasis; T cell

Indexed keywords

CHEMOKINE; CHEMOTACTIC FACTOR; GROWTH FACTOR;

ANGIOGENESIS; ANIMAL; BIOLOGICAL MODEL; BLOOD; CARCINOGENESIS; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; EFFECTOR CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; LEUKOCYTE; MACROPHAGE MIGRATION; METABOLISM; METASTASIS; NATURAL KILLER CELL; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHYSIOLOGY; REGULATORY MECHANISM; REVIEW; T LYMPHOCYTE; TUMOR GROWTH; TUMOR PROMOTION;

ANIMALS; CHEMOKINES; DENDRITIC CELLS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES;

EID: 0036005889     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(01)00033-8     Document Type: Review

References (158)

1. Chemokines
2. The biology of chemokines and their receptors
3. Chemokines: A new classification system and their role in immunity
4. Purification of melanoma growth stimulatory activity
5. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes
6. Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells
7. Effects of MGSA/GROα on melanocyte transformation
8. Enhanced tumor-forming capacity for immortalized melanocytes expressing melanoma growth stimulatory activity/growth-regulated cytokine β and γ proteins
9. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma
10. Autocrine growth effect of IL-8 and GROα on a human pancreatic cancer cell line, Capan-1
11. Reversible inhibition of IL-8 receptor β mRNA expression and proliferation in non-small-cell lung cancer by antisense oligonucleotides
12. G protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator
13. Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma
14. Point mutation causing constitutive signaling of CXCR2 leads to transforming activity similar to Kaposi's sarcoma herpesvirus-G protein-coupled receptor
15. Detection and localization of MIP-3αLARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer
16. A B cell-homing chemokine made in lymphoid follicles activates Burkitt's lymphoma receptor-1
17. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5
18. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma
19. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis
20. Inhibition of interleukin-8 attenuates angiogenesis in bronchogenic carcinoma
21. Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides
22. Human interferon-inducible protein-10 is a potent inhibitor of angiogenesis in vivo
23. The role of CXC chemokines in the regulation of angiogenesis in non-small-cell lung cancer
24. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3
25. Anti-tumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms
26. Cell cycle-dependent expression of CXC chemokine receptor-3 by endothelial cells mediates angiostatic activity
27. Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein-10
28. Tumor cell responses to IFNγ affect tumorigenicity and response to IL-12 therapy and angiogenesis
29. IP-10, a CXC chemokine, elicits a potent thymus-dependent anti-tumor response in vivo
30. Mig, the monokine induced by interferon-γ, promotes tumor necrosis in vivo
31. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis
32. Interleukin-8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer
33. Chemokines induce migrational responses in human breast carcinoma cell lines
34. Purification and identification of mouse lung microvessel endothelial cell-derived chemoattractant for lung-metastasizing murine RAW117 large-cell lymphoma cells: Identification as mouse monocyte chemotactic protein
35. Chemokines and their role in tumor growth and metastasis
36. The distribution of secondary growths in cancer of the breast
37. Involvement of chemokine receptors in breast cancer metastasis
38. Epithelial cancer cell migration: A role for chemokine receptors
39. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas
40. The origin and function of tumor-associated macrophages
41. Regulation of the macrophage content of neoplasms by chemoattractants
42. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor (TDCF)) is identical to monocyte chemo-attractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF)
43. Urinary levels of monocyte chemoattractant protein-1 correlate with tumour stage and grade in patients with bladder cancer
44. Differential expression of the monocyte chemoattractant protein-1 gene in human papillomavirus-16-infected squamous intraepithelial lesions and squamous cell carcinomas of the cervix uteri
45. Monocyte chemoattractant protein-1 (MCP-1) gene expression in cervical intraepithelial neoplasias and cervical carcinomas
46. The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer
47. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokines
48. Monocyte chemoattractant protein-1 (MCP-1) expression in primary lymphoepithelioma-like carcinomas (LELCs) of the lung
49. Macrophage infiltration in human non-small-cell lung cancer: The role of CC chemokines
50. Expression of monocyte chemotactic protein-1 in human invasive ductal breast cancer
51. Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer
52. Tumor-derived monocyte chemoattractant protein-1 induces intra-tumoral infiltration of monocyte-derived macrophage subpopulation in transplanted rat tumors
53. Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MPC-2 and -3) belonging to the chemokine family
54. Defective expression of the monocyte chemotactic protein-1 receptor CCR2 in macrophages associated with human ovarian carcinoma
55. Tumor-induced immune dysfunction: The macrophage connection
56. Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1
57. Comparison of microvessel density with tumor-associated macrophages in invasive breast carcinoma
58. The host-tumor immune conflict: From immunosuppression to resistance and destruction
59. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes
60. Suppression of tumor formation in vivo by expression of the JE gene in malignant cells
61. Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells
62. Monocyte chemoattractant protein-1 stimulates tumor necrosis and recruitment of macrophages into tumors in tumor-bearing nude mice: Increased granulocyte and macrophage progenitors in murine bone marrow
63. Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo
64. Monocyte chemotactic cytokine gene transfer modulates macrophage infiltration, growth, and susceptibility to IL-2 therapy of a murine melanoma
65. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
66. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
67. The role of chemokine receptors in primary, effector, and memory immune responses
68. RANTES secretion by gene-modified tumor cells results in loss of tumorigenicity in vivo: Role of immune cell subpopulations
69. Strong cytotoxic T lymphocyte responses to a macrophage inflammatory protein-1α expressing tumor: Linkage between inflammation and specific immunity
70. A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: Implication for the intense tumor infiltration by T lymphocytes and macrophages
71. Correlation of tissue and plasma RANTES levels with disease course in patients with breast or cervical cancer
72. Elevated expression of the CC chemokine regulated on activation, normal T cell expressed and secreted (RANTES) in advanced breast carcinoma
73. Chemokine receptor desensitization in tumor-bearing mice
74. A potential immune escape mechanism by melanoma cells through the activation of chemokine-induced T cell death
75. Mig and IP-10: CXC chemokines that target lymphocytes
76. Strong expression of the lymphoattractant CXC chemokine Mig is associated with heavy infiltration of T cells in human malignant melanoma
77. Expression and function of CXC and CC chemokines in human malignant liver tumors: A role for human monokine induced by interferon-γ in lymphocyte recruitment to hepatocellular carcinoma
78. Immunopotentiating role of IFN-γ in early and late stages of type I CD8 effector cell-mediated tumor rejection
79. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors
80. IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy
81. Combined chemokine and cytokine gene transfer enhances anti-tumor immunity
82. Adenoviral vectors expressing lymphotactin and interleukin-2 or lymphotactin and interleukin-12 synergize to facilitate tumor regression in murine breast cancer models
83. Lymphotactin expression by engineered myeloma cells drives tumor regression: Mediation by CD4(+) and CD8(+) T cells and neutrophils expressing XCR1 receptor
84. Chemokines in lymphopoiesis and lymphoid organ development
85. Secondary lymphoid tissue chemokine mediates T cell-dependent anti-tumor responses in vivo
86. Enhancement of anti-tumor immunity by tumor cells transfected with the secondary lymphoid tissue chemokine EBI-1-ligand chemokine and stromal cell-derived factor-1α chemokine genes
87. Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes and granulocytes
88. Reduced tumorigenicity and augmented leukocyte infiltration after monocyte chemotactic protein-3 (MCP-3) gene transfer: Perivascular accumulation of dendritic cells in peritumoral tissue and neutrophil recruitment within the tumor
89. Macrophage inflammatory protein-3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth
90. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas
91. CC chemokine receptor-6 is expressed on diverse memory subsets of T cells and determines responsiveness to macrophage inflammatory protein-3α
92. TARC a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T cell-rich B cell lymphoma, and most cases of anaplastic large-cell lymphoma
93. Expression of cytokine and chemokine genes in Epstein-Barr virus-associated nasopharyngeal carcinoma: Comparison with Hodgkin's disease
94. Chemoattractants MDC and TARC are secreted by malignant B cell precursors following CD40 ligation and support the migration of leukemia-specific T cells
95. Contribution of natural killer cells to inhibition of angiogenesis by interleukin-12
96. Natural killer cell-dependent suppression of systemic spread of human lung adenocarcinoma cells by monocyte chemoattractant protein-1 gene transfection in severe combined immunodeficient mice
97. The CC chemokine CKβ-11/MIP-3β/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells
98. Activation of dual T cell signaling pathways by the chemokine RANTES
99. RANTES and MIP-1α activate stats in T cells
100. Chemokines as regulators of T cell differentiation
101. α and β chemokines induce NK cell migration and enhance NK-mediated cytolysis
102. Chemokines activate natural killer cells through heterotrimeric G proteins: Implications for the treatment of AIDS and cancer
103. Regulation of dendritic cell trafficking: A process that involves the participation of selective chemokines
104. Chemokines and dendritic cell traffic
105. Dendritic cells and the control of immunity
106. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites
107. Cancer tumor antigens
108. Design and evaluation of antigen-specific vaccination strategies against cancer
109. Processing of engulfed apoptotic bodies yields T cell epitopes
110. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs
111. Immunogenicity of apoptotic cells in vivo: Role of antigen load, antigen-presenting cells, and cytokines
112. Natural adjuvants: Endogenous activators of dendritic cells
113. Consequences of cell death: Exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells
114. Dendritic cells as adjuvants for immune-mediated resistance to tumors
115. The dendritic cell and human cancer vaccines
116. Prognostic significance of accessory cells and lymphocytes in nasopharyngeal carcinoma
117. S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival
118. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma
119. Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer
120. Papillary carcinoma of the thyroid: Hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells
121. In vivo description of dendritic cells in human renal cell carcinoma
122. Infiltration of dendritic cells in relation to tumor invasion and lymph node metastasis in human gastric cancer
123. Tumor-infiltrating dendritic cells in neoplasms with a correlation to usual prognostic factors and to clinical outcome
124. Dendritic cell lineage, plasticity and cross-regulation
125. Reciprocal control of T helper cell and dendritic cell differentiation
126. The nature of the principal type I interferon-producing cells in human blood
127. Interferon-α and -β adjuvant therapy of high-risk resected cutaneous melanoma: The Eastern Cooperative Oncology Group Trial EST1684
128. Distinct CpG DNA and polyinosinic-polycytidylic acid double-stranded RNA, respectively, stimulate CD11c- type II dendritic cell precursors and CD11c+ dendritic cells to produce type I IFN
129. T cell-dependent anti-tumor immunity mediated by secondary lymphoid tissue chemokine: Augmentation of dendritic cell-based immunotherapy
130. CCR7 ligands, SLC/6Ckine/Exodus 2/TCA4 and CKβ-11/MIP-3β/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors
131. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo
132. Designer dendritic cells for tolerance induction: Guided not misguided missiles
133. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells
134. Cutting edge: Differential effect of apoptotic versus necrotic tumor cells on macrophage anti-tumor activities
135. A discrete subpopulation of dendritic cells transports apoptotic intestinal epithelial cells to T cell areas of mesenteric lymph nodes
136. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: Critical role in migration from the tumor site to draining lymph nodes
137. Differentiation of T regulatory cells by immature dendritic cells
138. Regulatory T cells in autoimmmunity
139. Induction of interleukin-10-producing, non-proliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells
140. Induction of tolerance by IL-10-treated dendritic cells
141. A CD4+ T cell subset inhibits antigen-specific T cell responses and prevents colitis
142. Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells
143. Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin-10 and induce the differentiation of T helper type II cells
144. Resting respiratory tract dendritic cells preferentially stimulate T helper cell type II (Th2) responses and require obligatory cytokine signals for induction of Th1 immunity
145. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen
146. Contrasting effects of TGFβ-1 and TNFα on the development of dendritic cells from progenitors in mouse bone marrow
147. TGFβ-1 prevents the non-cognate maturation of human dendritic Langerhans cells
148. Induction of tumor immunity by removing CD25+CD4+ T cells: A common basis between tumor immunity and autoimmunity
149. Prostaglandin E2 induces the final maturation of IL-12-deficient CD1a+CD83+ dendritic cells: The levels of IL-12 are determined during the final dendritic cell maturation and are resistant to further modulation
150. Evidence for the involvement of interleukin-10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2
151. Non-small-cell lung cancer-derived soluble mediators and prostaglandin E2 enhance peripheral blood lymphocyte IL-10 transcription and protein production
152. T cell priming by types I and II polarized dendritic cells: The concept of a third signal
153. Immunosuppressive effects of apoptotic cells
154. 2, and PAF
155. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization
156. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs
157. Ectopic expression of the chemokine TCA4/SLC is sufficient to trigger lymphoid neogenesis
158. Lymphoid tissue homing chemokines are expressed in chronic inflammation